Abstract
In a recent meta-analysis, intraparenchymal hemorrhage secondary to treatment by a flow-diverter stent (FDS) was reported in 3% of the cases.[1][1] Most of these hemorrhages were periprocedural complications. More surprising cases of delayed ipsilateral hemorrhage have been reported lately in
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have